Analysis of components of the CD14/TLR system on leukocytes of patients with atopic dermatitis

International Archives of Allergy and Immunology

Volumn 143, Issue 3, 2007, Pages 177-184

  Sümegi, Andrea ^a   Szegedi, Andrea ^a   Gál, Mónika ^a   Hunyadi, János ^a   Szegedi, Gyula ^a,b   Antal Szalmás, Péter ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Atopic dermatitis; CD14; CD180; Toll like receptor 2; Toll like receptor 4

Indexed keywords

ANTIGEN; CD14 ANTIGEN; CD180 ANTIGEN; ENDOTOXIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL INFECTION; BACTERIUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; UPREGULATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD14; DERMATITIS, ATOPIC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTES; MALE; TOLL-LIKE RECEPTORS;

EID: 34250307607     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099309     Document Type: Article

References (38)

1. Leung DY: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-876.
2. Wüthrich B: Atopic dermatitis flare provoked by inhalant allergens. Dermatologica 1989;178:51-53.
3. Öhman S, Johansson SG: Immunoglobulins in atopic dermatitis with special reference to IgE. Acta Derm Venereol 1974;54:193-202.
4. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol 2004;113:832-836.
5. Novak N, Bieber T: Allergic and nonallergic forms of atopic diseases. J Aller Clin Immunol 2003;112:252-262.
6. Leung DY: Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol 2001;45:S13-16.
7. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, et al: Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993;92:1374-1380.
8. Horner AA, Raz E: Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Curr Opin Immunol 2003;15:614-619.
9. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, et al: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999;274:33419-33425.
10. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, et al: Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000;105:497-504.
11. Frey EA, Miller DS, Jahr TG, et al: Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-1671.
12. Pulendran B: Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 2004;199:227-50.
13. Antal-Szalmás P, Poppelier MJJG, Sümegi A, Van der Bruggen T, Verhoef J, Van Kessel KPM, et al: Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. Immunol Letters 2004;93:11-15.
14. Antal-Szalmás P, Szöllosi I, Lakos G, Kiss E, Csípo I, Sümegi A, et al: A novel flow cytometric assay to quantify soluble CD14 concentration in human serum. Cytometry 2001;45:115-123.
15. Zarember KA, Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168:554-561.
16. Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F, et al: Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J Immunol 1996;157:4119-4125.
17. Leung DY, Jain N, Leo HL: New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003;15:634-638.
18. Leung DY: Infection in atopic dermatitis. Curr Opin Pediatr 2003;15:399-404.
19. Galli E, Cicconi R, Rossi P, Casati A, Brunetti E, Mancino G: Atopic dermatitis: molecular mechanisms, clinical aspects and new therapeutical approaches. Curr Mol Med 2003;3:127-138.
20. Cho SH, Strickland I, Boguniewicz M, Leung DY: Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001;108:269-274.
21. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
22. Antal-Szalmás P: Evaluation of CD14 in host defence. Eur J Clin Invest 2000;30:167-179.
23. Hadley JS, Wang JE, Foster SJ, Thiemermann C, Hinds CJ: Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect Immun 2005;73:7613-7619.
24. Wittebole X, Coyle SM, Kumar A, Goshima M, Lowry SF, Calvano SE: Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leukocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating. Clin Exp Immunol 2005;141:99-106.
25. Tsujimoto H, Ono S, Majima T, Kawarabayashi N, Takayama E, Kinoshita M, et al: Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 2005;23:39-44.
26. Harter L, Mica L, Stocker R, Trentz O, Keel M: Increased expression of Toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004;22:403-409.
27. Nagai Y, Shimazu R, Ogata H, Akashi S, Sudo K, Yamasaki H, et al: Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 2002;99;1699-1705.
28. Kimoto M, Nagasawa K, Miyake K: Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand J Infect Dis 2003;35;568-572.
29. Ricci G, Patrizi A, Neri I, Bendandi B, Masi M: Frequency and clinical role of Staphylococcus aureus overinfection in atopic dermatitis in children. Pediatr Dermatol 2003;20:389-392.
30. Novak N, Allam JP, Bierber T: Allergic hyperreactivity to microbial components: a trigger factor of 'intrinsic' atopic dermatitis? J Allergy Clin Immunol 2003;112:215-216.
31. Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P: Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 1993;23:2144-2151.
32. Zdolsek HA, Jenmalm MC: Reduced levels of soluble CD14 in atopic children. Clin Exp Allergy 2004;34:532-539.
33. Wüthrich B, Kagi MK, Joller-Jemelka H: Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992;284:339-342.
34. Furue M, Koga T, Yamashita N: Soluble Eselectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999;140:67-72.
35. Blumenthal MN: New thoughts regarding the genetics of atopy. Am J Respir Crit Care Med 2004;169:555-556.
36. O'Donnell AR, Toelle BG, Marks GB, Hayden CM, Laing IA, Peat JK, et al: Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med 2004;169:615-622.
37. Smith KB, Ellis SA: Standardisation of a procedure for quantifying surface antigens by indirect immunofluorescence. J Immunol Methods 1999;228:29-36.
38. Antal-Szalmas P, Van Strijp JA, Weersink AJ, Verhoef J, Van Kessel KP: Quantitation of surface CD14 on human monocytes and